about
A momentary biomarker for depressive moodUrinary Biomarkers of Brain DiseasesMaking Sense of Blood-Based Proteomics and Metabolomics in Psychiatric ResearchOmics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric DisordersObesity and psychotic disorders: uncovering common mechanisms through metabolomicsCytosolic Accumulation of L-Proline Disrupts GABA-Ergic Transmission through GAD BlockadeInflammation and the two-hit hypothesis of schizophrenia.Changes in retinal metabolic profiles associated with form deprivation myopia development in guinea pigs.Reconstruction and analysis of correlation networks based on GC-MS metabolomics data for young hypertensive men.A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight mass spectrometry studyThe potential biomarker panels for identification of Major Depressive Disorder (MDD) patients with and without early life stress (ELS) by metabonomic analysis.Novel urinary metabolite signature for diagnosing postpartum depressionQuantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients.Integrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disorders.Impaired metabolic reactivity to oxidative stress in early psychosis patientsEvidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophreniaAltered coupling of regional cerebral blood flow and brain temperature in schizophrenia compared with bipolar disorder and healthy subjectsSex-specific urinary biomarkers for diagnosing bipolar disorder.Metabolite profiling in posttraumatic stress disorder.Urinary metabonomics for diagnosis of depression in hepatitis B virus-infected patients.Comparison of paroxetine and agomelatine in depressed type 2 diabetes mellitus patients: a double-blind, randomized, clinical trial.Potential of serum metabolites for diagnosing post-stroke cognitive impairment.Metabolomics Approach Reveals Integrated Metabolic Network Associated with Serotonin Deficiency.Plasma Metabolic Profiles in Women are Menopause Dependent.Relationship between Erythrocyte Fatty Acid Composition and Psychopathology in the Vienna Omega-3 StudySerum trace element differences between Schizophrenia patients and controls in the Han Chinese population.Schizophrenia shows a unique metabolomics signature in plasmaPotential serum biomarkers from a metabolomics study of autismIdentification and validation of urinary metabolite biomarkers for major depressive disorderComparative Circadian Metabolomics Reveal Differential Effects of Nutritional Challenge in the Serum and LiverRandom forest in clinical metabolomics for phenotypic discrimination and biomarker selection.Metabolomic Profiling of Post-Mortem Brain Reveals Changes in Amino Acid and Glucose Metabolism in Mental Illness Compared with ControlsThe Brain Metabolome of Male Rats across the Lifespan.Metabolomic Analysis in Brain Research: Opportunities and ChallengesA combined metabonomic and proteomic approach identifies frontal cortex changes in a chronic phencyclidine rat model in relation to human schizophrenia brain pathologyIdentification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR- and GC-MS-based metabonomics.Modified Mediterranean Diet for Enrichment of Short Chain Fatty Acids: Potential Adjunctive Therapeutic to Target Immune and Metabolic Dysfunction in Schizophrenia?Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder.Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease.Carbonyl stress and schizophrenia.
P2860
Q26765408-AED66B9B-3F00-4834-B4E1-1446771189D0Q26769944-EF64D884-3DD6-4735-9FCD-5881E0A43894Q26771434-6A27EF82-4566-4138-95E5-1092E409E4B0Q26784904-01225481-72C8-43AA-8B1C-6626DADF607AQ27011617-30E0E202-35D2-4D4C-AF3E-0485CE2BDB4FQ30370117-45A91AA5-D427-41FC-8F4C-F867358B9896Q30422062-A0E7DDAC-D1B5-4CD2-BE62-453DBDB1A5F8Q30854785-C051B616-553A-4D10-A9C4-90B56C405628Q30874878-2C4DA9C1-80D2-492A-B569-FFAC0035DF5DQ33575018-6B099D46-074E-47F9-AEDD-5D7A7F171B00Q33679513-67BAF78A-0416-4A1E-8DC5-18FA61E456A4Q33704082-907D4DCF-098B-40DF-B0AC-41C3C6822669Q33863985-A9B3A23D-5D14-4394-945B-2C90CB455A3FQ33945211-0729631C-99D9-404B-830F-272DA801E5C6Q34048645-21E99EBC-19C5-44D9-90C9-6D0CB1638298Q34113374-0FAA0736-6DF9-4C9A-BFAF-F14DDC8C3D86Q34727281-F2659D1E-254D-4380-8978-618983156107Q34757521-405BE54D-1004-418E-957B-8ECA22195A20Q35200833-B6E93A93-C65D-4726-AF56-86BF215A0911Q35645024-113AC404-77BD-406E-92D4-B92F0CDBBA94Q35683830-79D534A1-6E9D-48F1-9DA9-F14034BEE3C3Q35816838-DBDEF8F6-91FD-45C1-8537-9C4F1FC1BF8BQ35829940-2AFAD559-8640-49AF-A7B2-6F11859D2C9FQ35845210-89DA9E48-A28C-4F61-901F-C2823EE95E3EQ35952743-83AA1E20-1196-473C-94BC-72D20864531DQ36146659-F8FD470F-9F43-46C4-B732-7C22B7D4DDBEQ36203421-262FE9F5-7B94-4A43-8252-471DA1F7CEBBQ36395466-AED37944-A266-4616-8C87-BD966C5C1219Q36508139-A1EFE9AA-FBB6-486D-9EA9-84E668C0B751Q36548377-CE8FE4BD-BAFE-4007-858D-0CE9FCAC58C9Q36676574-50D8A555-02D6-4E61-987E-46032832D0F3Q36743314-FBD4B7C8-BA23-4800-87A3-7C3634577E22Q36785265-91041D4B-06E1-4A74-AA82-404FDF31A52CQ36930380-48F0CC07-19D4-431A-BC32-136D10C69447Q37235856-7C43AB3D-DE78-4199-955A-A5F6DF49F840Q37648213-D9888685-2282-4EE5-93D2-5E56CD39235BQ37721268-D17D17AE-955C-4852-A06E-570C26C0A7E4Q37733240-7D6B1CC1-5CC1-4963-BB49-7BE517E8D93EQ38051186-24808028-B77A-4AAC-B976-2B897618C255Q38226316-CB819EC4-B7E1-4433-8EB8-C09112CA0A89
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Potential metabolite markers of schizophrenia.
@ast
Potential metabolite markers of schizophrenia.
@en
type
label
Potential metabolite markers of schizophrenia.
@ast
Potential metabolite markers of schizophrenia.
@en
prefLabel
Potential metabolite markers of schizophrenia.
@ast
Potential metabolite markers of schizophrenia.
@en
P2093
P2860
P50
P356
P1433
P1476
Potential metabolite markers of schizophrenia
@en
P2093
P2860
P2888
P356
10.1038/MP.2011.131
P407
P577
2011-10-25T00:00:00Z